Breast cancer risk assessment solution

Designed to enable earlier detection

Empower your OB-GYN, radiology, and surgery teams with Myriad Genetics’ testing and personal family history analysis to identify patients at elevated risk.

Identify the 1 in 4 women who meet criteria for hereditary cancer genetic testing1

We integrate seamlessly to:

Enhance care with early interventions

Offer genetic education
at no cost 

Strengthen equitable access to tools and services

Foster loyalty through
personalized care

Myriad’s breast cancer risk assessment program overview

Our workflows are designed to integrate with a health system’s or clinic’s unique end-to-end experience. We help your radiology, OB-GYN, or surgery departments to: 

  • identify the right patients
  • create operational efficiencies
  • enable care management with clear medical management tools

Myriad’s breast cancer risk assessment program overview 

  • Patient Identification
  • Testing Patients
  • Managing Care

    Myriad’s breast cancer risk assessment program overview 

    • Patient Identification
    • Testing Patients
    • Testing Patients
    • Managing Care

      Learn how we can help elevate and enhance patient care

      By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.


      Hidden Fields









      Pioneers in genetic testing and precision medicine

      We continue to innovate across hereditary cancer risk, oncology, reproductive health, urology, and mental health. Partnering with providers and patients to provide actionable genetic insights from one lab for a streamlined experience that simplifies solutions and reduces variant discordance.

      Historic highlights

      • Isolated the location of the BRCA1 and BRCA2 genes
      • Brought the first genetic test to market to assess hereditary breast and ovarian cancer risk, the MyRisk Hereditary Cancer Test
      • Introduced MyRisk with RiskScore®, the only personalized breast cancer risk assessment for patients of all ancestries
      • Created the first genetic prognostic test for prostate cancer patients, Prolaris®
      • Developed GeneSight®, the leading pharmacogenomics (PGx) test to support physicians in prescribing medications for patients with anxiety, depression and ADHD
      • Introduced Precise Oncology Solutions® by combining genetic insights from multiple tests to help guide treatment decisions and improve patient care

      1M+

      total annual number of genetic tests performed

      1,000+

      scientific publications

      50,000+

      active ordering physicians

      Learn more

      Cancer treatment made clear

      Genetic and genomic testing can provide the answers you’re looking for to create personalized medical management plans for more effective patient care.

      More confident patient care begins with your patients’ genes

      With the right hereditary cancer test, you can uncover valuable insights and answers that empower you and your patient to do more to help prevent cancer or diagnose it at an earlier, more treatable stage.

      1. Nazareth S, et al. Hereditary cancer risk using a genetic chatbot before routine care visits. Obstetrics & Gynecology. 2021;138(6):860-870.